Axios reports on renewed shortages of several generic chemotherapy drugs, raising concerns that some cancer treatments may need to be delayed or rationed. The article cites data from Premier showing declining hospital fill rates for critical medications, including cisplatin and ifosfamide, and highlights Premier’s insights into the manufacturing disruptions contributing to ongoing supply constraints.
